Epoprostenol in Pulmonary Embolism

Summary

You are admitted to hospital because of pulmonary embolism. You are treated with anticoagulants. The investigators know that, despite this treatment, pulmonary embolism can be a threat especially if heart function is compromized. The investigators investigate a well known study drug (epoprostenol) on top of regular treatment with anticoagulants, to see if heart function can be optimized

Timeline

Start

2004-01

Primary completion

2006-06

Completion

2006-06

Publications

• Kooter AJ, Ijzerman RG, Kamp O, Boonstra AB, Smulders YM. No effect of epoprostenol on right ventricular diameter in patients with acute pulmonary embolism: a randomized controlled trial. BMC Pulm Med. 2010 Mar 30;10:18. doi: 10.1186/1471-2466-10-18.

Drugs

Indications